Edgewise Therapeutics (NASDAQ:EWTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Edgewise Therapeutics Stock (NASDAQ: EWTX) stock price, news, charts, stock research, profile.

Open	$35.24
Close	$35.20
Volume / Avg.	804.62K / 1.15M
Day Range	$34.00 - $35.99
52 Wk Range	5.12 - 38.12
Market Cap	$3.33B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	11.26%
Days to Cover	9.37

Recent News

Analysts Think There's Still Time To Get In On Edgewise

Edgewise Therapeutics (NASDAQ: EWTX) is a small-cap pharmaceutical stock that has been all the rage recently. Shares are up 55% in the last three months and up 332% over the past 52 weeks.

MarketBeat

Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge

Edgewise Therapeutics (NASDAQ: EWTX) is up 50% in a single session and 450% from recent lows for a reason. Its novel, oral, selective treatment for obstructive hypertrophic cardiomyopathy did remarkably well in early trials.

MarketBeat

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$35.24
Close	$35.20
Volume / Avg.	804.62K / 1.15M
Day Range	$34.00 - $35.99
52 Wk Range	5.12 - 38.12
Market Cap	$3.33B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	11.26%
Days to Cover	9.37

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Edgewise Therapeutics (EWTX) stock?

You can purchase shares of Edgewise Therapeutics (NASDAQ:EWTX) through any online brokerage.

View our list of the best stock brokerages

Who are Edgewise Therapeutics (EWTX) competitors?

Other companies in Edgewise Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Edgewise Therapeutics (EWTX) stock?

Edgewise Therapeutics has a consensus price target of $33.86.

What is the current price for Edgewise Therapeutics (EWTX)?

The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $35.2 last updated November 12, 2024 at 4:00 PM EST.

Does Edgewise Therapeutics (EWTX) pay a dividend?

There are no upcoming dividends for Edgewise Therapeutics.

When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?

Edgewise Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Edgewise Therapeutics (EWTX) going to split?

There is no upcoming split for Edgewise Therapeutics.

What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Edgewise Therapeutics

Edgewise Therapeutics (EWTX) Forecast